Pure Global
NCT06403592

The Effect of a Laryngeal Mask Airway on Optic Nerve Sheath Diameter

Erasmus Medical Center·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Intracranial Pressure Increase
Drug/Device/Intervention
optic nerve sheath diamater
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Erasmus Medical Center
Location
Rotterdam, Netherlands
Timeline & enrollment
Phase
N/A
Start date
Mar 25, 2024
End date
Mar 25, 2026
Enrollment
230 participants
Primary outcome

Effect of insertion of a laryngeal airway mask on optic nerve sheath diameter

Summary

The goal of this observational trial is to study the effect of a laryngeal airway mask on the
 optic nerve sheath diameter, as a surrogate for intracranial pressure.
 
 The optic nerve sheath diameter of participants will be measured under general anesthesia,
 before, during and after insertion of a laryngeal airway mask.

ICD-10 classifications
Benign intracranial hypertensionIntracranial injuryIntracranial injury, unspecifiedOther intracranial injuriesIntracranial hypotension following ventricular shunting
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06403592
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06403592 through Pure Global AI's free database. This phase not specified trial is sponsored by Erasmus Medical Center and is currently Recruiting. The study focuses on Intracranial Pressure Increase. Target enrollment is 230 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.